STAT2 min. leídos
STAT+: Pharmalittle: Pharma Would Lose Loyal Ally If Menendez Leaves Senate; EMA To Discuss Anesthesia Risk For Weight-loss Drugs
With mounting calls for U.S. Sen. Bob Menendez to resign, the pharmaceutical industry could lose one of its increasingly rare Democratic allies.
STAT1 min. leídos
STAT+: The Ozempic Revolution Is Rooted In The Work Of Svetlana Mojsov, Yet She’s Been Edged Out Of The Story
Svetlana Mojsov, on the discovery of GLP-1: “This is not about me getting prizes. It’s about me actually not being erased from the scientific literature.”
STAT1 min. leídos
Opinion: STAT+: The Problem With Potential Changes To The Biosimilar Regulatory Framework
There is no evidence to suggest that the current regulatory framework inhibits biosimilar uptake.
STAT2 min. leídos
STAT+: Pharmalittle: FDA To Furlough One-fifth Of Staff If Government Shuts Down; FDA Cites ‘Grossly Deficient’ Data For ALS Drug
If U.S. lawmakers are unable to prevent a government shutdown by Oct. 1, the FDA will have to furlough almost one-fifth of its staff.
STAT1 min. leídos
STAT+: Cancer Drug Shortages Widen Disparities Between Big Systems And Small
"I just worry about the precedent that, once again, the big institutions get this advantage over private practices.”
STAT1 min. leídos
STAT+: Pharmalittle: End Of Biotech’s Stock Market Malaise May Be Near; Cancer Drug Shortages Hit Rural Clinics Hard
This was supposed to be the year the biotech industry recovered from its ongoing slump, but that simply hasn’t happened.
STAT1 min. leídos
STAT+: What Ever Happened To Biotech’s Big Comeback?
The XBI biotech index has fallen more than 10% in 2023, while the S&P 500 rose about 13%. But there’s optimism heading into the last quarter of the year.
STAT2 min. leídos
STAT+: Pharmalittle: More Than 9 In 10 Pharmacy Techs Report Drug Shortages; Yale And VA Strike Deal Over Ketamine Patent Royalties
Yale and one of its professors agreed to settle allegations that they wrongly withheld patent royalties for ketamine-related inventions.
STAT2 min. leídos
STAT+: Pharmalittle: FDA Finds Problems At Novo’s Main U.S. Factory; Polarizing ALS Drug Heads For FDA Scrutiny
FDA inspectors issued a report detailing quality control lapses at Novo Nordisk's main factory in North America as early as May last year.
STAT2 min. leídos
STAT+: Pharmalittle: Lilly Sues Spas And Compounders Over ‘Unapproved’ Mounjaro; Nasal-spray EpiPen Alternative Suffers Setback
Eli Lilly sued several compounding pharmacies, spas, and wellness centers for selling unapproved versions of Mounjaro.
STAT1 min. leídos
STAT+: How A Cash-prize System That Phases Out Patents May Lower Drug Prices
"The idea here is you can still get a patent but it wouldn’t be implemented as a monopoly on a drug or vaccine or other medical technology."
STAT2 min. leídos
STAT+: Pharmalittle: Cepheid Agrees To Sell A TB Test At Cost; Mallinckrodt Weighs Selling Some Or All Businesses
A company that makes a crucial TB test has agreed to sell its product at cost for use in poor countries.
STAT2 min. leídos
STAT+: Pharmalittle: U.S. Chamber And Feds Clash On Medicare Price Negotiation; South Africa Probes J&J Over TB-drug Pricing
Chamber and government lawyers sparred over whether drugmakers have enough say in Medicare’s drug price-negotiation program.
STAT2 min. leídos
STAT+: Pharmalittle: House Panel Inches Into Fixing Drug Shortages; Pharma Could Face Legal Action Over Improper Patent Listings
A House committee took a first step toward legislation to fix hospital drug shortages, but do not expect a new law soon.
STAT1 min. leídos
Opinion: The Morally Ground-shifting Legacy Of Ian Wilmut And Dolly The Sheep
Ian Wilmut, the British scientist behind the first-ever cloning of a mammal, died Sept. 10, leaving behind a twofold legacy.
STAT2 min. leídos
STAT+: Pharmalittle: White House Imposes Price Limits For Regeneron Covid Drug; Lawmakers Push Federal Agencies To Prevent Patent Abuses
A HHS deal for a Regeneron drug marks the first time the administration has directly used its leverage to challenge list prices.
STAT2 min. leídos
STAT+: Pharmalittle: FDA Panel Says Popular Decongestant Doesn’t Work; U.S. Warns Companies Over Illegally Marketed Eye Products
The leading decongestant used by millions of Americans is no better than a dummy pill, FDA scientiific advisers concluded.
STAT1 min. leídos
STAT+: Neurocrine Biosciences Drug For Congenital Adrenal Hyperplasia Succeeds In Late-stage Trial
Neurocrine Biosciences announced on Tuesday that an experimental drug for congenital adrenal hyperplasia succeeded in a late-stage trial.
STAT1 min. leídos
STAT+: FDA Proposes Changes To Key Approval Pathway For Medical Devices, Five Years After Promising
The FDA issued new guidelines clarifying the way they plan to evaluate medical devices that go through the controversial 510(k) pathway.
STAT2 min. leídos
STAT+: Pharmalittle: Is Pascal Soriot Leaving AstraZeneca? PBMs Try To Counter Congressional Crackdown
AstraZeneca appeared to play down speculation about CEO Pascal Soriot after a U.K. tabloid report that he was considering leaving.
STAT1 min. leídos
STAT+: Pharmalittle: Biden’s NIH Nominee Will Get A Hearing; Top Democrat Backs Bill To Ban PBM Spread Pricing
President Biden’s nominee to lead NIH will get a hearing next month, perhaps thanks to a drug-pricing deal.
STAT1 min. leídos
STAT+: Pharmalittle: Novartis R&D Hub’s Name Change Reflects Strategy Shift; Lilly’s Mounjaro Backed By U.K. Watchdog
Novartis is changing the name — and the guiding strategy — of its research and development hub in Cambridge, Mass.
STAT1 min. leídos
STAT+: Lawsuit Raises Antitrust And Kickback Allegations Around Cancer Patient Referrals
Oncologists in Philadelphia are alleging Jefferson Health system is violating federal antitrust and kickback laws by creating a “concerted campaign to eliminate” the group’s “presence in the oncology marketplace.”
STAT1 min. leídos
Not Yet Free From Heroin’s Grip, An ‘Honest, Funny Man’ Finds His Way Off The Streets
“Maybe somebody is not yet ready for recovery, but that does not mean that they don’t deserve safety and peace and rest.”
STAT2 min. leídos
STAT+: Pharmalittle: South Africa ‘Bullied’ Into One-sided Covid Vaccine Deals; Astellas Drops Medicare Price-negotiation Suit
Vaccine contracts show South Africa was “bullied” into one-sided deals with Covid-19 shot suppliers.
STAT1 min. leídos
STAT+: Amazon’s Chief Medical Officers On Where The Company’s Health Care Bets Are Headed Next
“If we're going to do it, let's make sure we're leveraging things that Amazon does really well, which is connecting buyers and sellers,” said Nworah Ayogu, Amazon Clinic’s chief medical…
… o descubre algo nuevo